These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The reaction to the test dose of d-tubocurarine before anaesthesia in myasthenic and hypersensitive patients. HALL P Acta Anaesthesiol Scand; 1958; 2(3):117-22. PubMed ID: 13594045 [No Abstract] [Full Text] [Related]
8. Continuous treatment of myasthenia gravis with prednisone. Dalby A; Kjaer M; de Fine Olivarius B Lancet; 1971 Mar; 1(7699):597-8. PubMed ID: 4100930 [No Abstract] [Full Text] [Related]
10. [Predictive factors of the response to treatment of myasthenia gravis with prednisone]. Pradas J; Illa I Neurologia; 1990 Jan; 5(1):11-3. PubMed ID: 2361025 [TBL] [Abstract][Full Text] [Related]
11. Studies in neuromuscular function. VI. Effects of anticholinesterase compounds, d-tubocurarine, and decamethonium in patients with myasthenia gravis. GROB D; HARVEY AM; JOHNS RJ Bull Johns Hopkins Hosp; 1956 Oct; 99(4):219-38. PubMed ID: 13364533 [No Abstract] [Full Text] [Related]
13. [Corticosteroid therapy in myasthenia gravis: preliminary considerations on the long-term treatment with prednisone]. Cornelio F; Caraceni T; Negri S Riv Neurobiol; 1974; 20(14):78-86. PubMed ID: 4220136 [No Abstract] [Full Text] [Related]
14. Disseminated thymoma and myasthenia gravis: dramatic response to prednisone. Taylor R; Tandan R; Roberts J; DiCostanzo DP; Sharma K; Fries T Ann Neurol; 1989 Feb; 25(2):208-9. PubMed ID: 2919872 [No Abstract] [Full Text] [Related]
15. Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment. Seybold ME; Drachman DB N Engl J Med; 1974 Jan; 290(2):81-4. PubMed ID: 4808454 [No Abstract] [Full Text] [Related]
16. [Large dose of prednisone in the treatment of the oculomuscular type of myasthenia gravis]. Wang DC Zhonghua Yan Ke Za Zhi; 1984 Jul; 20(4):245-7. PubMed ID: 6439528 [No Abstract] [Full Text] [Related]
17. Cryptococcal cellulitis in a patient on prednisone monotherapy for myasthenia gravis. Lafleur L; Beaty S; Colome-Grimmer MI; LaForte RA; Dotson AD Cutis; 2004 Sep; 74(3):165-70. PubMed ID: 15499758 [TBL] [Abstract][Full Text] [Related]
18. Long-term corticosteroid treatment of myasthenia gravis. Johns TR Ann N Y Acad Sci; 1987; 505():568-83. PubMed ID: 3479938 [No Abstract] [Full Text] [Related]
19. Critical assessment of the local curare test in myasthenia gravis. Boiardi A; Bussone G; Negri S Eur Neurol; 1977; 15(5):275-80. PubMed ID: 913440 [TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis as a guide for azathioprine therapy in prednisone-resistant myasthenia gravis. Rodnitzky RL; Bosch EP Muscle Nerve; 1981; 4(6):529-30. PubMed ID: 7311992 [No Abstract] [Full Text] [Related] [Next] [New Search]